Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites
The deal would expand Lonza’s U.S. CDMO network from four to nine sites and grow the company’s U.S. workforce nearly 25% by adding approximately 1,100 employees, resulting in a combined headcount of more than 6,000 employees. The post Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites appeared first on GEN - Genetic Engineering and Biotechnology News .
The deal would expand Lonza’s U.S. CDMO network from four to nine sites and grow the company’s U.S. workforce nearly 25% by adding approximately 1,100 employees, resulting in a combined headcount of more than 6,000 employees. The post Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites appeared first on GEN - Genetic Engineering and Biotechnology News .
This is a summary of the story. Read the full article at GEN — Genetic Engineering & Biotechnology News ↗